Furthermore, the study of Alb-CCN2 mice allowed us to demonstrate that hepatic CCN2 production during NASH drives and exacerbates HSC activation and collagen deposition. This evidence concerns the gene ALB and metabolic dysfunction-associated steatohepatitis.